Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial

T. B. Powles; B. Escudier; P. de Souza; S. Chowdhury; D. Pook; U. Harmenberg; N. Basappa; D. Geynisman; J. Merchan; B. G. Redman; C. Ryan; O. Goodman; T. Ho; P. Singh; J. Lougheed; M. Patel; J. J. Knox; R. J. Motzer; T. K. Choueiri

doi:10.1093/annonc/mdw373.41

Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial

T. B. Powles, B. Escudier, P. de Souza, S. Chowdhury, D. Pook, U. Harmenberg, N. Basappa, D. Geynisman, J. Merchan, B. G. Redman, C. Ryan, O. Goodman, T. Ho, P. Singh, J. Lougheed, M. Patel, J. J. Knox, R. J. Motzer, T. K. Choueiri

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	814P
Number of pages	1
Journal	Annals of Oncology
Volume	27
Issue number	S6
DOIs	https://doi.org/10.1093/annonc/mdw373.41
Publication status	Published - 1 Oct 2016
Externally published	Yes

Access to Document

10.1093/annonc/mdw373.41

304138571-oaFinal published version, 38 KB

Cite this

Powles, T. B., Escudier, B., de Souza, P., Chowdhury, S., Pook, D., Harmenberg, U., Basappa, N., Geynisman, D., Merchan, J., Redman, B. G., Ryan, C., Goodman, O., Ho, T., Singh, P., Lougheed, J., Patel, M., Knox, J. J., Motzer, R. J., & Choueiri, T. K. (2016). Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial. Annals of Oncology, 27(S6), [814P]. https://doi.org/10.1093/annonc/mdw373.41

@article{ef34ecb2482c43daa080bf3f751f2967,

title = "Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial",

author = "Powles, {T. B.} and B. Escudier and {de Souza}, P. and S. Chowdhury and D. Pook and U. Harmenberg and N. Basappa and D. Geynisman and J. Merchan and Redman, {B. G.} and C. Ryan and O. Goodman and T. Ho and P. Singh and J. Lougheed and M. Patel and Knox, {J. J.} and Motzer, {R. J.} and Choueiri, {T. K.}",

year = "2016",

month = oct,

day = "1",

doi = "10.1093/annonc/mdw373.41",

language = "English",

volume = "27",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "S6",

}

Powles, TB, Escudier, B, de Souza, P, Chowdhury, S, Pook, D, Harmenberg, U, Basappa, N, Geynisman, D, Merchan, J, Redman, BG, Ryan, C, Goodman, O, Ho, T, Singh, P, Lougheed, J, Patel, M, Knox, JJ, Motzer, RJ & Choueiri, TK 2016, 'Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial', Annals of Oncology, vol. 27, no. S6, 814P. https://doi.org/10.1093/annonc/mdw373.41

TY - JOUR

T1 - Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial

AU - Powles, T. B.

AU - Escudier, B.

AU - de Souza, P.

AU - Chowdhury, S.

AU - Pook, D.

AU - Harmenberg, U.

AU - Basappa, N.

AU - Geynisman, D.

AU - Merchan, J.

AU - Redman, B. G.

AU - Ryan, C.

AU - Goodman, O.

AU - Ho, T.

AU - Singh, P.

AU - Lougheed, J.

AU - Patel, M.

AU - Knox, J. J.

AU - Motzer, R. J.

AU - Choueiri, T. K.

PY - 2016/10/1

Y1 - 2016/10/1

U2 - 10.1093/annonc/mdw373.41

DO - 10.1093/annonc/mdw373.41

M3 - Meeting Abstract

VL - 27

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - S6

M1 - 814P

ER -